Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Nalina Chandrasekharan

Pediatrics Tomball, TX Medical Doctor

NPI 1104967025 CMS profile 50567

11011 Northpointe Blvd Ste C, Tomball, TX 77375

Open in the dashboard

General payments

$1,942

89 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$187,696 paid to institutions, not to them · program years 2023–2025

Through program year 2025, Nalina Chandrasekharan of Tomball, TX is reported in the CMS Open Payments database as having received $1,942 across 89 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $187,696 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $331 17
2024 General $357 17
2023 General $420 16
2022 General $253 14
2021 General $220 10
2020 General $105 4
2019 General $255 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nalina Chandrasekharan
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Nalina Chandrasekharan were reported at $331. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Nalina Chandrasekharan Pediatrics median Middle half National median
2019 $255 $86 $31–$183 $163
2020 $105 $49 $22–$110 $114
2021 $220 $68 $27–$158 $132
2022 $253 $77 $30–$173 $149
2023 $420 $88 $33–$190 $160
2024 $357 $94 $34–$206 $164
2025 $331 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. GlaxoSmithKline, LLC. $582 22 payments
  2. Ironshore Pharmaceuticals Inc. $241 12 payments
  3. Cranial Technologies, Inc $190 12 payments
  4. Tris Pharma Inc $149 2 payments
  5. Pfizer Inc. $139 8 payments
  6. Verrica Pharmaceuticals Inc. $98 5 payments
  7. Merck Sharp & Dohme Corporation $66 5 payments
  8. Sobi, Inc $55 2 payments
  9. Phadia US Inc. $43 2 payments
  10. Dexcom, Inc. $39 2 payments
  11. Other $339 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,942 89 payments
Products named General payments · program years 2019–2025
  1. BEXSERO $582 22 payments
  2. PEDIARIX $365 16 payments
  3. Doc Band $190 12 payments
  4. JORNAY PM Central Nervous System Stimulant $162 7 payments
  5. Quillichew ER $125 1 payment
  6. Quillivant $125 1 payment
  7. Dyanavel XR $125 1 payment
  8. YCANTH $98 5 payments
  9. ROTATEQ $66 5 payments
  10. JORNAY PM Central Nervous Stimulant ADHD $61 4 payments
  11. Other $1,069 57 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

89 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record